Medication-Assisted Treatment Data

Note:
We update this information every quarter.

Note:
Here we use data from Rhode Island Department of Health (RIDOH), Substance Abuse and Mental Health Services Administration (SAMHSA), Rhode Island Department of Behavioral Healthcare, Developmental Disabilities and Hospitals (BHDDH), and Alkermes.

The number of Rhode Islanders on medication-assisted treatment (MAT) is on the rise

Methadone, buprenorphine, and naltrexone are evidence-based treatments for opioid addiction (also called opioid use disorder). A key initiative under the Governor’s action plan is to increase the number of people accessing MAT. Learn more about our action plan to address addiction and overdose in Rhode Island.
Source (RIDOH) Source (BHDDH) Source (VIVITROL)

Buprenorphine treatment capacity in Rhode Island has more than doubled since 2016

Rhode Island has increased the number of trained and Drug Addiction Treatment Act (DATA)-waivered practitioners who are able to prescribe buprenorphine as medication-assisted treatment.

Source (RIDOH)

Medication-assisted treatment options are available throughout Rhode Island

Find a treatment provider in your community on our Find Treatment page.
Source (SAMHSA Buprenorphine) Source (SAMHSA Methadone) Source (Alkermes)

↑ Back to Top